Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Shailja C Shah"'
Autor:
Christina P. Wang, Meg McKinley, Annie Vu, Jeong Yun Yang, Samir Gupta, Scarlett L. Gomez, Michelle Kang Kim, Steven H. Itzkowitz, Shailja C. Shah
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 4, Pp 482-490 (2024)
Background and Aims: Gastrointestinal cancer incidence varies by race and ethnicity. In the United States (US), there are screening guidelines for esophageal cancer (EC) and colorectal cancer (CRC), but not gastric cancer (GC). We compared GC, CRC, a
Externí odkaz:
https://doaj.org/article/d807e3a74adf4287bfea5385b3d5199c
Autor:
Shailja C. Shah, Rohan Gupta, Ranier Bustamante, Mark Lamm, Hanin Yassin, Ashley Earles, Adriana Hung, Alese Halvorson, Robert Greevy, Samir Gupta, Joshua Demb, Lin Liu, Christianne L. Roumie
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 1, Pp 78-83 (2024)
Background and Aims: There are limited contemporary population-based data on Helicobacter pylori epidemiology and outcomes in the United States. Our primary aim was to create a validated cohort of veterans with H pylori testing or treatment using Vet
Externí odkaz:
https://doaj.org/article/abb35ed0286b4b78bff7ad214faa3f62
Autor:
Sony Tuteja, Zhihong Yu, Otis Wilson, Hua‐Chang Chen, Frank Wendt, Cecilia P. Chung, Shailja C. Shah, Christine M. Hunt, Ayako Suzuki, Catherine Chanfreau, Bryan R. Gorman, Jacob Joseph, Shiuh‐Wen Luoh, Valerio Napolioni, Cassianne Robinson‐Cohen, Ran Tao, Jin Zhou, Kyong‐Mi Chang, Adriana M. Hung, the VA Million Veteran Program COVID‐19 Science Initiative
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 8, Pp 1880-1886 (2022)
Abstract Remdesivir is the first US Food and Drug Administration (FDA)‐approved drug for the treatment of coronavirus disease 2019 (COVID‐19). We conducted a retrospective pharmacogenetic study to examine remdesivir‐associated liver enzyme elev
Externí odkaz:
https://doaj.org/article/7bae9f9cc503422b9e1b5d18da448c25
Autor:
Shailja C. Shah, Andrew Canakis, Alese E. Halvorson, Chad Dorn, Otis Wilson, Jason Denton, Richard Hauger, Christine Hunt, Ayako Suzuki, Michael E. Matheny, Edward Siew, Adriana Hung, Robert A. Greevy, Jr., Christianne L. Roumie
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 6, Pp 977-984 (2022)
Background and Aims: Gastrointestinal (GI) symptoms are well-recognized manifestations of coronavirus disease 2019 (COVID-19). Our primary objective was to evaluate the association between GI symptoms and COVID-19 severity. Methods: In this nationwid
Externí odkaz:
https://doaj.org/article/70197cf5fecd4414a45013d5f016b3c0
Autor:
Sheeva K. Parbhu, Shailja C. Shah, Michael J. Sossenheimer, John C. Fang, Kathryn A. Peterson, Andrew J. Gawron
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Gastric intestinal metaplasia (GIM) is a premalignant gastric mucosal change that is often incidentally detected during esophagogastroduodenoscopy (EGD). Despite the established higher risk of gastric cancer associated with GIM, the incid
Externí odkaz:
https://doaj.org/article/3e91f410f0ad4c7b9b6e82949499eb53
Autor:
Jennifer M. Noto, M. Blanca Piazuelo, Shailja C. Shah, Judith Romero-Gallo, Jessica L. Hart, Chao Di, James D. Carmichael, Alberto G. Delgado, Alese E. Halvorson, Robert A. Greevy, Lydia E. Wroblewski, Ayushi Sharma, Annabelle B. Newton, Margaret M. Allaman, Keith T. Wilson, M. Kay Washington, M. Wade Calcutt, Kevin L. Schey, Bethany P. Cummings, Charles R. Flynn, Joseph P. Zackular, Richard M. Peek Jr.
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 10 (2022)
Gastric carcinogenesis is mediated by complex interactions among Helicobacter pylori, host, and environmental factors. Here, we demonstrate that H. pylori augmented gastric injury in INS-GAS mice under iron-deficient conditions. Mechanistically, thes
Externí odkaz:
https://doaj.org/article/7d198f5f9fa7400583ab84388b9c0680
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Autoimmune gastritis (AIG) is a chronic immune-mediated, inflammatory condition that involves the destruction of the gastric oxyntic mucosa through the autoimmune-mediated loss of parietal cells, with replacement by atrophic and metaplastic tissue. D
Externí odkaz:
https://doaj.org/article/d24ed4ed66d447a4a06d420dc86a1f55
Autor:
Shailja C. Shah, Chiaki Nakata, Alexandros D. Polydorides, Richard M. Peek, Steven H. Itzkowitz
Publikováno v:
Journal of Preventive Medicine and Public Health, Vol 52, Iss 3, Pp 179-187 (2019)
Objectives: In the USA, certain races and ethnicities have a disproportionately higher gastric cancer burden. Selective screening might allow for earlier detection and curative resection. Among a USA-based multiracial and ethnic cohort diagnosed with
Externí odkaz:
https://doaj.org/article/c3fce6ec30384d70a8a2ed73ea37a4e3
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-8 (2019)
The rising prevalence of noncommunicable diseases globally, with a strikingly disproportionate increase in prevalence and related mortality in low- and middle-income countries (LMICs), is a major threat to sustainable development. The epidemiologic t
Externí odkaz:
https://doaj.org/article/3df6ee29a18243c5b66cc8cca8ab3d10
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
The inflammatory bowel diseases (IBD), comprising Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, progressive, inflammatory conditions of the gastrointestinal tract. Imbalance in the gut microbial community, or dysbiosis, and the sub
Externí odkaz:
https://doaj.org/article/2b50901ec2714878b1472514f7bedc3a